In control?: Ukrainian opiate substitution treatment patients strive for a voice in their treatment

Substance Use and Misuse

Volumn 47, Issue 5, 2012, Pages 511-521

  Golovanevskaya, Maria ^a   Vlasenko, Leonid ^b   Saucier, Roxanne ^c  

^a OPEN SOCIETY FOUNDATIONS   (United States)

^b Drug User Treatment Expert   (Ukraine)

^c Independent Consultant   (United States)

Author keywords

Drug use; Opiate substitution treatment; Patient advocacy; Police; Ukraine

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; DRUG USE; FEMALE; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MIDDLE AGED; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PATIENT ADVOCACY; PATIENT PARTICIPATION; POLICE; SELF CONCEPT; UKRAINE; URBAN POPULATION;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; DRUG USERS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT ADVOCACY; PATIENT PARTICIPATION; POLICE; SELF EFFICACY; UKRAINE; URBAN POPULATION;

EID: 84858773675     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2012.644117     Document Type: Review

References (22)

1. Babayan, E. A., & Gonopolsky, M. H. (1981). Uchebnoe posobie po narkologii. New York: International Universities Press.
2. Bruce, R. D., Dvoryak, S., Sylla, L., & Altice, F. A. (2007). HIV treatment access and scale-up for delivery for IDU in Ukraine with opiate substitution therapy with buprenorphine - programme description and policy implications. International Journal of Drug Policy, 18, 326-328. (Pubitemid 47135596)
3. Cohen, J. (2010). Law enforcement and drug treatment: A culture clash. Science, 329(5988), 169.
4. Dumchev, K. V., Soldyshev, R., Qian, H. -Z., Zezyulin, O. O., Chandler, S. D., Slobodyanyuk, P., et al. (2009). HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: A cross-sectional survey. Harm Reduction Journal, 6, 23.
5. Dvoryak, S., & Skala, P. (2008). Substitution maintenance therapy in Ukraine: Can the community respond effectively to the challenges of HIV/AIDS. Kiev: International HIV/AIDS Alliance in Ukraine.
6. Elovich, R., & Drucker, E. (2008). On drug treatment and social control: Russian narcology's great leap backwards. Harm Reduction Journal, 5, 23.
7. Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews, Issue 2, No. CD004145. doi: 10. 1002/14651858. CD004145. pub3.
8. HIV/AIDS Alliance in Ukraine. (2009). Statistics: Number of new officially registered cases of HIV infection, AIDS, and lethal outcomes. Retrieved 4 September 2010, from http://www.aidsalliance. org. ua/cgi-bin/index. cgi?url=/ua/library/statistics/index.htm [in Russian].
9. Human Rights Watch. (2006). Risk and rhetoric: Human rights abuses impeding Ukraine's fight against HIV/AIDS. New York: Human Rights Watch.
10. International Dual Loyalty Working Group. (2002). Dual loyalty and human rights in health professional practice: Proposed guidelines and institutional mechanisms. Cambridge, MA: Physicians for Human Rights and School of Public Health and Primary Health Care, Health Sciences Faculty, University of Cape Town.
11. Kruglov, Y. V., Kobyshcha, Y. V., Salyuk, T., Varetska, O., Shakarishvili, A., & Saldanha, V. P. (2008). The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007. Sexually Transmitted Infections, 84(Suppl. 1), i37-i41.
12. Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008). Buprenorphine maintenance versus placebo ormethadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, Issue 2. No. CD002207. doi: 10. 1002/14651858.
13. Ministry of Health. (1978). Duration of minimimally required terms of treatment of patients that abuse narcotics, and toxic substances (Order No. 388 of the Ministry of Health of the USSR of 19 April 1978). Moscow: Author.
14. Roux, P., Carrieri, M. P., Cohen, J., Ravaux, I., Poizot Martin, I., Dellamonica, P., et al. (2009). Retention in opioid substitution treatment:Amajor predictor of long-Term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clinical Infectious Diseases, 49(9), 1433-1440.
15. Schaub, M., Chtenguelov, V., Subata, E., Weller, G., & Uchtenhagen, A. (2010). Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine. International Journal of Drug Policy, 21(3), 229-233.
16. Shields, A. (2009). The effects of drug user registration laws on people's rights and health: Findings from Russia, Georgia, and Ukraine. New York: Open Society Institute.
17. Thorne, C., Semenenko, I., Pilipenko, T., & Malyuta, R. (2009). The Ukraine European Collaborative Study Group progress in prevention of mother-To-child transmission of HIV infection in Ukraine: Results from a birth cohort study. BMC Infectious Diseases, 9, 40.
18. Tolopilo, A., & Vlasenko, L. (2008). Drug user registration: Practices, consequences, and the future [in Russian]. Kiev:Ukrainian Institute of Public Health Policy.
19. Uchtenhagen, A., & Shaub, M. (2010). Final monitoring and evaluation report on opioid substitution treatment in Ukraine. Zurich: Research Institute for Public Health and Addiction and Zurich University.
20. Ukrainian Institute on Public Health Policy. (2010). Data on the number of patients in OST programs as of August 15, 2010. Retrieved 4 September 2010, from http://www.uiphp. org. ua/ua/resource/zvedeni-danni/[in Russian].
21. Wolfe, D. (2007). Paradoxes in antiretroviral treatment for injecting drug users: Access, adherence and structural barriers in Asia and the former Soviet Union. International Journal of Drug Policy, 18(4), 246-254. (Pubitemid 47135597)
22. World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC), and United Nations Program on HIV/AIDS (UNAIDS). (2009). Technical guide for countries to set targets for universal access toHIV prevention, treatment, and care for injecting drug users. Geneva: WHO.